These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1247 related articles for article (PubMed ID: 34358692)

  • 41. Guillain-​Barré Syndrome Associated with COVID-19 Vaccination.
    Shao SC; Wang CH; Chang KC; Hung MJ; Chen HY; Liao SC
    Emerg Infect Dis; 2021 Dec; 27(12):3175-3178. PubMed ID: 34648420
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comment on "SARS-CoV-2 vaccinations may not only be complicated by GBS but also by distal small fiber neuropathy by J. Finsterer.
    Galassi G
    J Neuroimmunol; 2022 Aug; 369():577901. PubMed ID: 35667183
    [No Abstract]   [Full Text] [Related]  

  • 43. Population-Based Incidence of Guillain-Barré Syndrome During Mass Immunization With Viral Vaccines: A Pooled Analysis.
    Wang F; Wang D; Wang Y; Li C; Zheng Y; Guo Z; Liu P; Zhang Y; Wang W; Wang Y; Hou H
    Front Immunol; 2022; 13():782198. PubMed ID: 35185881
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Two possible etiologies of Guillain-Barré syndrome: mRNA-1273 (Moderna) vaccination and scrub typhus: A case report.
    Hwang BW; Bong JB
    Medicine (Baltimore); 2022 Dec; 101(48):e32140. PubMed ID: 36482517
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Case of Guillain-Barré syndrome following COVID-19 vaccine.
    Hasan T; Khan M; Khan F; Hamza G
    BMJ Case Rep; 2021 Jun; 14(6):. PubMed ID: 34187803
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [A Patient Developing Guillain-Barré Syndrome After Receiving the BNT162b2 COVID-19 mRNA Vaccine].
    Oshibe N; Honda M; Koga M; Sato R; Oishi M; Kanda T
    Brain Nerve; 2022 Aug; 74(8):1025-1030. PubMed ID: 35941801
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Post COVID-19 vaccination Guillain-Barre syndrome: three cases.
    Tabatabaee S; Rezania F; Alwedaie SMJ; Malekdar E; Badi Z; Tabatabaei SM; Mirzaasgari Z
    Hum Vaccin Immunother; 2022 Nov; 18(5):2045153. PubMed ID: 35240922
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Guillain-Barré syndrome following BNT162b2 COVID-19 vaccine.
    Trimboli M; Zoleo P; Arabia G; Gambardella A
    Neurol Sci; 2021 Nov; 42(11):4401-4402. PubMed ID: 34346014
    [No Abstract]   [Full Text] [Related]  

  • 49. Guillain-Barré Syndrome Associated with COVID-19 Vaccination.
    Finsterer J; Scorza FA; Scorza CA
    Emerg Infect Dis; 2022 May; 28(5):1079-1080. PubMed ID: 35447058
    [No Abstract]   [Full Text] [Related]  

  • 50. Guillain-Barré Syndrome and COVID-19 Vaccine: A Multicenter Retrospective Study of 46 Cases.
    Castiglione JI; Crespo JM; Bendersky M; Silveira FO; Lecchini L; Luis MB; Zambrano FC; Cotti N; Simison CJ; Aguirre F; Piedrabuena MA; Alonso RN; Azcona CL; Sosa PS; Maldonado E; Varela F; Bettini M; Rey RD; Cejas LL; Rugiero M; Reisin R; Barroso F
    J Clin Neuromuscul Dis; 2023 Sep; 25(1):1-10. PubMed ID: 37611264
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Guillain-Barré Syndrome Following the mRNA COVID-19 Vaccination: Comment.
    Mungmunpuntipantip R; Wiwanitkit V
    Acta Neurol Taiwan; 2023 Dec; 32(4)():228-229. PubMed ID: 37781729
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Guillain-Barré syndrome after COVID-19 vaccination: report of two cases from Vietnam.
    Hai PD; Phuong LL; Tot NH; Anh NLP; Tung ND; Quan NH
    J Infect Dev Ctries; 2022 Nov; 16(11):1703-1705. PubMed ID: 36449641
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of a delayed second dose of mRNA vaccine (BNT162b2) and inactivated SARS-CoV-2 vaccine (CoronaVac) on risks of all-cause mortality, emergency department visit, and unscheduled hospitalization.
    Wong CKH; Xiong X; Lau KTK; Chui CSL; Lai FTT; Li X; Chan EWY; Wan EYF; Au ICH; Cowling BJ; Lee CK; Wong ICK
    BMC Med; 2022 Mar; 20(1):119. PubMed ID: 35296305
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Before SARS-CoV-2 Vaccine is Held Responsible for Guillain-Barre Syndrome, Other Causes Must be Removed From the Table.
    Finsterer J
    J Clin Neuromuscul Dis; 2024 Mar; 25(3):146-148. PubMed ID: 38441933
    [No Abstract]   [Full Text] [Related]  

  • 55. Guillain-Barré Syndrome Associated with COVID-19 Vaccines: A Perspective From Spontaneous Report Data.
    Atzenhoffer M; Auffret M; Pegat A; Masmoudi K; Khouri C; Bertin B; Vial T
    Clin Drug Investig; 2022 Jul; 42(7):581-592. PubMed ID: 35676452
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Guillain-Barré syndrome and COVID-19: A 1-year observational multicenter study.
    Filosto M; Cotti Piccinelli S; Gazzina S; Foresti C; Frigeni B; Servalli MC; Sessa M; Cosentino G; Marchioni E; Ravaglia S; Briani C; Castellani F; Zara G; Bianchi F; Del Carro U; Fazio R; Filippi M; Magni E; Natalini G; Palmerini F; Perotti AM; Bellomo A; Osio M; Nascimbene C; Carpo M; Rasera A; Squintani G; Doneddu PE; Bertasi V; Cotelli MS; Bertolasi L; Fabrizi GM; Ferrari S; Ranieri F; Caprioli F; Grappa E; Manganotti P; Bellavita G; Furlanis G; De Maria G; Leggio U; Poli L; Rasulo F; Latronico N; Nobile-Orazio E; Beghi E; Padovani A; Uncini A
    Eur J Neurol; 2022 Nov; 29(11):3358-3367. PubMed ID: 35837806
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In brief: Guillain-Barré syndrome with the Johnson and Johnson COVID-19 vaccine.
    Med Lett Drugs Ther; 2021 Aug; 63(1630):121. PubMed ID: 34550109
    [No Abstract]   [Full Text] [Related]  

  • 58. Guillain-Barré Syndrome After Ad26.COV2.S Vaccination.
    Thant HL; Morgan R; Paese MM; Persaud T; Diaz J; Hurtado L
    Am J Case Rep; 2022 Feb; 23():e935275. PubMed ID: 35157644
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
    Haas EJ; Angulo FJ; McLaughlin JM; Anis E; Singer SR; Khan F; Brooks N; Smaja M; Mircus G; Pan K; Southern J; Swerdlow DL; Jodar L; Levy Y; Alroy-Preis S
    Lancet; 2021 May; 397(10287):1819-1829. PubMed ID: 33964222
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Experience of treatment in critical Guillain-Barre Syndrome case after COVID-19 vaccination.
    Zhu C; Wang H; Zhang Y; Wang W; Wang J; Li W
    Int J Dev Neurosci; 2024 Jun; 84(4):342-348. PubMed ID: 38590219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 63.